Annual Total Liabilities
$39.75 B
+$373.00 M+0.95%
December 31, 2024
Summary
- As of March 6, 2025, GILD annual total liabilities is $39.75 billion, with the most recent change of +$373.00 million (+0.95%) on December 31, 2024.
- During the last 3 years, GILD annual total liabilities has fallen by -$7.14 billion (-15.23%).
- GILD annual total liabilities is now -20.80% below its all-time high of $50.19 billion, reached on December 31, 2020.
Performance
GILD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$39.75 B
+$3.61 B+10.00%
December 31, 2024
Summary
- As of March 6, 2025, GILD quarterly total liabilities is $39.75 billion, with the most recent change of +$3.61 billion (+10.00%) on December 31, 2024.
- Over the past year, GILD quarterly total liabilities has increased by +$3.61 billion (+10.00%).
- GILD quarterly total liabilities is now -20.80% below its all-time high of $50.19 billion, reached on December 31, 2020.
Performance
GILD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GILD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.9% | +10.0% |
| 3 y3 years | -15.2% | +10.0% |
| 5 y5 years | +2.0% | +10.0% |
GILD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.2% | +0.9% | -15.2% | +12.3% |
| 5 y | 5-year | -20.8% | +2.0% | -20.8% | +12.3% |
| alltime | all time | -20.8% | >+9999.0% | -20.8% | >+9999.0% |
Gilead Sciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $39.75 B(+0.9%) | $39.75 B(+10.0%) |
| Sep 2024 | - | $36.13 B(+2.1%) |
| Jun 2024 | - | $35.38 B(-8.9%) |
| Mar 2024 | - | $38.84 B(-1.4%) |
| Dec 2023 | $39.38 B(-6.2%) | $39.38 B(-1.9%) |
| Sep 2023 | - | $40.13 B(-2.7%) |
| Jun 2023 | - | $41.24 B(+0.7%) |
| Mar 2023 | - | $40.94 B(-2.4%) |
| Dec 2022 | $41.96 B(-10.5%) | $41.96 B(+1.1%) |
| Sep 2022 | - | $41.50 B(-2.7%) |
| Jun 2022 | - | $42.66 B(-1.2%) |
| Mar 2022 | - | $43.16 B(-7.9%) |
| Dec 2021 | $46.89 B(-6.6%) | $46.89 B(+2.8%) |
| Sep 2021 | - | $45.63 B(-5.5%) |
| Jun 2021 | - | $48.27 B(-0.5%) |
| Mar 2021 | - | $48.53 B(-3.3%) |
| Dec 2020 | $50.19 B(+28.8%) | $50.19 B(+15.6%) |
| Sep 2020 | - | $43.41 B(+14.9%) |
| Jun 2020 | - | $37.79 B(+0.6%) |
| Mar 2020 | - | $37.56 B(-3.6%) |
| Dec 2019 | $38.98 B(-7.5%) | $38.98 B(+1.5%) |
| Sep 2019 | - | $38.41 B(-5.1%) |
| Jun 2019 | - | $40.46 B(-0.7%) |
| Mar 2019 | - | $40.75 B(-3.3%) |
| Dec 2018 | $42.14 B(-15.3%) | $42.14 B(+2.0%) |
| Sep 2018 | - | $41.30 B(-5.3%) |
| Jun 2018 | - | $43.62 B(-2.5%) |
| Mar 2018 | - | $44.73 B(-10.1%) |
| Dec 2017 | $49.78 B(+32.3%) | $49.78 B(+26.3%) |
| Sep 2017 | - | $39.41 B(+6.0%) |
| Jun 2017 | - | $37.17 B(+1.1%) |
| Mar 2017 | - | $36.78 B(-2.2%) |
| Dec 2016 | $37.61 B(+15.4%) | $37.61 B(-4.2%) |
| Sep 2016 | - | $39.25 B(+15.9%) |
| Jun 2016 | - | $33.87 B(+0.4%) |
| Mar 2016 | - | $33.75 B(+3.5%) |
| Dec 2015 | $32.60 B(+73.0%) | $32.60 B(-0.3%) |
| Sep 2015 | - | $32.69 B(+45.1%) |
| Jun 2015 | - | $22.53 B(+8.7%) |
| Mar 2015 | - | $20.73 B(+10.0%) |
| Dec 2014 | $18.84 B(+73.9%) | $18.84 B(+25.8%) |
| Sep 2014 | - | $14.98 B(+1.4%) |
| Jun 2014 | - | $14.78 B(+2.8%) |
| Mar 2014 | - | $14.38 B(+32.7%) |
| Dec 2013 | $10.83 B(-7.4%) | $10.83 B(-3.9%) |
| Sep 2013 | - | $11.28 B(-0.0%) |
| Jun 2013 | - | $11.28 B(-4.6%) |
| Mar 2013 | - | $11.82 B(+1.1%) |
| Dec 2012 | $11.70 B(+12.1%) | $11.70 B(-4.2%) |
| Sep 2012 | - | $12.21 B(-1.6%) |
| Jun 2012 | - | $12.42 B(-1.3%) |
| Mar 2012 | - | $12.59 B(+20.6%) |
| Dec 2011 | $10.44 B(+90.8%) | $10.44 B(+62.9%) |
| Sep 2011 | - | $6.41 B(-1.2%) |
| Jun 2011 | - | $6.48 B(-4.8%) |
| Mar 2011 | - | $6.81 B(+24.5%) |
| Dec 2010 | $5.47 B(+71.3%) | $5.47 B(-1.9%) |
| Sep 2010 | - | $5.58 B(+46.9%) |
| Jun 2010 | - | $3.80 B(+18.9%) |
| Mar 2010 | - | $3.19 B(-0.0%) |
| Dec 2009 | $3.19 B(+29.2%) | $3.19 B(+0.3%) |
| Sep 2009 | - | $3.18 B(+3.6%) |
| Jun 2009 | - | $3.07 B(+22.8%) |
| Mar 2009 | - | $2.50 B(+1.3%) |
| Dec 2008 | $2.47 B | $2.47 B(-7.8%) |
| Sep 2008 | - | $2.68 B(+1.1%) |
| Jun 2008 | - | $2.65 B(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $2.44 B(+9.2%) |
| Dec 2007 | $2.23 B(+0.8%) | $2.23 B(+2.8%) |
| Sep 2007 | - | $2.17 B(-2.3%) |
| Jun 2007 | - | $2.23 B(+2.3%) |
| Mar 2007 | - | $2.17 B(-1.9%) |
| Dec 2006 | $2.22 B(+200.2%) | $2.22 B(+10.8%) |
| Sep 2006 | - | $2.00 B(+0.9%) |
| Jun 2006 | - | $1.98 B(+210.6%) |
| Mar 2006 | - | $638.07 M(-13.6%) |
| Dec 2005 | $738.54 M(+159.1%) | $738.54 M(+144.7%) |
| Sep 2005 | - | $301.82 M(+1.9%) |
| Jun 2005 | - | $296.08 M(-3.2%) |
| Mar 2005 | - | $306.02 M(+7.3%) |
| Dec 2004 | $285.09 M(-48.3%) | $285.09 M(-51.7%) |
| Sep 2004 | - | $590.40 M(+9.1%) |
| Jun 2004 | - | $541.30 M(-0.4%) |
| Mar 2004 | - | $543.42 M(-1.5%) |
| Dec 2003 | $551.75 M(-23.0%) | $551.75 M(-26.4%) |
| Sep 2003 | - | $749.81 M(+0.3%) |
| Jun 2003 | - | $747.86 M(+0.8%) |
| Mar 2003 | - | $741.59 M(+3.5%) |
| Dec 2002 | $716.84 M(+109.4%) | $716.84 M(+102.8%) |
| Sep 2002 | - | $353.40 M(+4.0%) |
| Jun 2002 | - | $339.94 M(+2.8%) |
| Mar 2002 | - | $330.79 M(-3.4%) |
| Dec 2001 | $342.35 M(+4.7%) | $342.35 M(+2.3%) |
| Sep 2001 | - | $334.80 M(+3.9%) |
| Jun 2001 | - | $322.25 M(-0.3%) |
| Mar 2001 | - | $323.20 M(-1.2%) |
| Dec 2000 | $326.98 M(+134.4%) | $326.98 M(+446.6%) |
| Sep 2000 | - | $59.81 M(-55.5%) |
| Jun 2000 | - | $134.33 M(+0.8%) |
| Mar 2000 | - | $133.28 M(-4.5%) |
| Dec 1999 | $139.52 M(-9.5%) | $139.52 M(-6.6%) |
| Sep 1999 | - | $149.40 M(+449.3%) |
| Jun 1999 | - | $27.20 M(-8.4%) |
| Mar 1999 | - | $29.70 M(-80.7%) |
| Dec 1998 | $154.10 M(+342.8%) | $154.10 M(+381.6%) |
| Sep 1998 | - | $32.00 M(-2.4%) |
| Jun 1998 | - | $32.80 M(-13.7%) |
| Mar 1998 | - | $38.00 M(+9.2%) |
| Dec 1997 | $34.80 M(+83.2%) | $34.80 M(+55.4%) |
| Sep 1997 | - | $22.40 M(-4.3%) |
| Jun 1997 | - | $23.40 M(-13.7%) |
| Mar 1997 | - | $27.10 M(+42.6%) |
| Dec 1996 | $19.00 M(+25.0%) | $19.00 M(+8.6%) |
| Sep 1996 | - | $17.50 M(+4.8%) |
| Jun 1996 | - | $16.70 M(-5.6%) |
| Mar 1996 | - | $17.70 M(+16.4%) |
| Dec 1995 | $15.20 M(-6.7%) | - |
| Sep 1995 | - | $15.20 M(+6.3%) |
| Jun 1995 | - | $14.30 M(-12.3%) |
| Mar 1995 | - | $16.30 M(-1.8%) |
| Mar 1995 | $16.30 M(+44.2%) | - |
| Dec 1994 | - | $16.60 M(-3.5%) |
| Sep 1994 | - | $17.20 M(+15.4%) |
| Jun 1994 | - | $14.90 M(+31.9%) |
| Mar 1994 | $11.30 M(+52.7%) | $11.30 M(+7.6%) |
| Dec 1993 | - | $10.50 M(+2.9%) |
| Sep 1993 | - | $10.20 M(+59.4%) |
| Jun 1993 | - | $6.40 M(-13.5%) |
| Mar 1993 | $7.40 M(+138.7%) | $7.40 M(+21.3%) |
| Dec 1992 | - | $6.10 M(+10.9%) |
| Sep 1992 | - | $5.50 M(+111.5%) |
| Jun 1992 | - | $2.60 M(-16.1%) |
| Mar 1992 | $3.10 M(+34.8%) | $3.10 M(+34.8%) |
| Mar 1991 | $2.30 M | $2.30 M |
FAQ
- What is Gilead Sciences annual total liabilities?
- What is the all time high annual total liabilities for Gilead Sciences?
- What is Gilead Sciences annual total liabilities year-on-year change?
- What is Gilead Sciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Gilead Sciences?
- What is Gilead Sciences quarterly total liabilities year-on-year change?
What is Gilead Sciences annual total liabilities?
The current annual total liabilities of GILD is $39.75 B
What is the all time high annual total liabilities for Gilead Sciences?
Gilead Sciences all-time high annual total liabilities is $50.19 B
What is Gilead Sciences annual total liabilities year-on-year change?
Over the past year, GILD annual total liabilities has changed by +$373.00 M (+0.95%)
What is Gilead Sciences quarterly total liabilities?
The current quarterly total liabilities of GILD is $39.75 B
What is the all time high quarterly total liabilities for Gilead Sciences?
Gilead Sciences all-time high quarterly total liabilities is $50.19 B
What is Gilead Sciences quarterly total liabilities year-on-year change?
Over the past year, GILD quarterly total liabilities has changed by +$3.61 B (+10.00%)